Pediatric Inflammatory Bowel Disease with Cytoplasmic Staining of Antineutrophil Cytoplasmic Antibodies

Table 2

Laboratory investigations of IBD patients with positive c-ANCA.

Patient	Hb (g/dL)	Platelets k/uL	Albumin (g/L)	CRP mg/L	ALT (IU)	ASCA-A	ASCA-G	Anti-MPO	Anti-PR3
Patient 1	9.4	731	32	148	23	Neg.	Pos.	Neg.	Pos.
Patient 2	12	655	36	120	37	Pos.	Neg.	Neg.	Pos.
Patient 3	9.6	650	22	30	21	Pos.	Neg.	Neg.	Pos.
Patient 4	10	381	43	16	35	Neg.	Neg.	Neg.	Pos.
Patient 5	6	785	24	80	22	Neg.	Neg.	Neg.	Pos.
Patient 6	8.3	587	36	41	41	Neg.	Neg.	Neg.	Pos.
Patient 7	11.2	434	33	23	23	Neg.	Neg.	Neg.	Pos.

Hb: hemoglobin, CRP: c-reactive protein, ALT: alanine aminotransferase, ASCA-A: IgA anti-Saccharomyces cerivisiae antibody, ASCA-G: IgG anti-Saccharomyces cerivisiae antibody, anti-MPO: myeloperoxidase antibody, anti-PR-3: serine proteinase-3 antibody, Pos.: positive, and Neg.: negative.